nonoxynol-9

(redirected from N-9)
Also found in: Dictionary, Acronyms.

nonoxynol-9

(nŏn-ŏk′sə-nôl′nīn′, -nŏl′-, -nōl′-)
n.
A spermicide widely used in contraceptive creams, foams, and lubricants.

nonoxynol-9

A SURFACTANT spermicidal drug intended for use in conjunction with barrier contraceptives. It is available as a foam, pessary, gel, or cream. Brand names are Delfen, Double Check, Ortho-Forms, Duragel, Gynol II and Ortho-Creme.
References in periodicals archive ?
I think the bottom line is that N-9 may be safe in those women who don't use it frequently and who are at low risk for HIV and STIs, and that's probably a lot of the women we see in our practices.
Since adverse effects due to the addition of N-9 to condoms cannot be excluded, such condoms should no longer be promoted.
On September 25 The Wall Street Journal published "Some Makers, Venders Drop N-9 Spermicide on HIV Risk.
And on September 28, 2002, The Lancet formally published results of a major study in Africa that showed that N-9 could increase HIV transmission--available at http://www.
Second, data correlating use of N-9 contraceptives with individual HIV risk were not available.
N-9 alone is not an effective means to prevent infection with HIV or cervical gonorrhea and chlamydia (2,7).
of Male condoms N-9 products + Region * women served No.
Whether N-9 adds contraceptive protection to barrier methods other than condoms is still unknown, although spermicide use with the diaphragm is recommended.
Organizers of the Call emphasize that removing N-9 from condoms and lubricants would benefit women as well as gay men.
Recent research has shown that even small amounts of N-9 can cause sloughing of the cell lining of the rectum, potentially increasing one's risk of contracting HIV," said Dr.
After presentation of the preliminary results from the study in July 2000, the World Health Organization (WHO) was approached to provide an assessment of the scientific information regarding the safety and effectiveness of N-9 when used for family planning purposes.
This report summarises the evidence presented to the meeting on the safety of N-9 and its effectiveness for protection against pregnancy, sexually transmitted infections (STIs) and HIV.